Core Scientific (CORZ) Free Cash Flow (2021 - 2026)

Core Scientific (CORZ) has 6 years of Free Cash Flow data on file, last reported at -$139.3 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 8.0% year-over-year to -$139.3 million; the trailing twelve-month figure through Mar 2026 stood at -$461.1 million (down 326.04% YoY), and the FY2025 full-year result was -$450.8 million, down 1150.8% from the prior year.
• Free Cash Flow retreated to -$139.3 million in Q1 2026, from -$121.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $116.0 million in Q4 2022 to a low of -$139.3 million in Q1 2026.
• A 5-year average of -$31.6 million and a median of -$26.1 million in 2022 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow soared 1153.65% in 2024 and slumped 7656.62% in 2025, its largest moves.
• Tracing CORZ's Free Cash Flow over 5 years: stood at $116.0 million in 2022, then tumbled by 94.5% to $6.4 million in 2023, then soared by 1153.65% to $80.0 million in 2024, then plunged by 252.16% to -$121.7 million in 2025, then dropped by 14.47% to -$139.3 million in 2026.
• Business Quant data shows CORZ's Free Cash Flow at -$139.3 million in Q1 2026, -$121.7 million in Q4 2025, and -$112.7 million in Q3 2025.